11-36509193-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.-23+855C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0844 in 152,300 control chromosomes in the GnomAD database, including 742 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.084 ( 742 hom., cov: 32)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.517

Publications

10 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.126 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
NM_004620.4
MANE Select
c.-23+855C>G
intron
N/ANP_004611.1
TRAF6
NM_145803.3
c.-116+855C>G
intron
N/ANP_665802.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
ENST00000526995.6
TSL:1 MANE Select
c.-23+855C>G
intron
N/AENSP00000433623.1
TRAF6
ENST00000348124.5
TSL:1
c.-116+855C>G
intron
N/AENSP00000337853.5

Frequencies

GnomAD3 genomes
AF:
0.0845
AC:
12864
AN:
152182
Hom.:
743
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0227
Gnomad AMI
AF:
0.0800
Gnomad AMR
AF:
0.0881
Gnomad ASJ
AF:
0.0935
Gnomad EAS
AF:
0.000769
Gnomad SAS
AF:
0.0215
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.128
Gnomad OTH
AF:
0.0861
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0844
AC:
12854
AN:
152300
Hom.:
742
Cov.:
32
AF XY:
0.0841
AC XY:
6261
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0227
AC:
942
AN:
41582
American (AMR)
AF:
0.0880
AC:
1346
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0935
AC:
324
AN:
3466
East Asian (EAS)
AF:
0.000771
AC:
4
AN:
5190
South Asian (SAS)
AF:
0.0213
AC:
103
AN:
4830
European-Finnish (FIN)
AF:
0.107
AC:
1132
AN:
10594
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.128
AC:
8725
AN:
68020
Other (OTH)
AF:
0.0852
AC:
180
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
631
1262
1892
2523
3154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0575
Hom.:
66
Bravo
AF:
0.0803
Asia WGS
AF:
0.0130
AC:
48
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.4
DANN
Benign
0.61
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030419; hg19: chr11-36530743; API